These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

20 related articles for article (PubMed ID: 6132457)

  • 1. A meta-analysis of the effectiveness of albendazole compared with metronidazole as treatments for infections with Giardia duodenalis.
    Solaymani-Mohammadi S; Genkinger JM; Loffredo CA; Singer SM
    PLoS Negl Trop Dis; 2010 May; 4(5):e682. PubMed ID: 20485492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by "amitochondriate" protozoan parasites.
    Ali V; Nozaki T
    Clin Microbiol Rev; 2007 Jan; 20(1):164-87. PubMed ID: 17223627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proceedings of the British Pharmacological Society. 9th-11th September 1985. Abstracts.
    Br J Pharmacol; 1985 Dec; 86 Suppl(Suppl):527P-820P. PubMed ID: 4084713
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative evaluation of the 2-methyl-5-nitroimidazole compounds dimetridazole, metronidazole, secnidazole, ornidazole, tinidazole, carnidazole, and panidazole against Bacteroides fragilis and other bacteria of the Bacteroides fragilis group.
    Jokipii L; Jokipii AM
    Antimicrob Agents Chemother; 1985 Oct; 28(4):561-4. PubMed ID: 4073879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mutagenic activity of nitrothiazole compounds].
    Hof H
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Jun; 181(1-2):64-70. PubMed ID: 3901605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenic activity of 4 active-principle forms of pharmaceutical drugs. Comparative study in the Salmonella typhimurium microsome test, and the HGPRT and Na+/K+ ATPase systems in cultured mammalian cells.
    Dayan J; Crajer MC; Deguingand S
    Mutat Res; 1982; 102(1):1-12. PubMed ID: 6289090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationship of nitroimidazo (2,1-b) thiazoles in the Salmonella mutagenicity assay.
    Biagi GL; Hrelia P; Guerra MC; Paolini M; Barbaro AM; Cantelli-Forti G
    Arch Toxicol Suppl; 1986; 9():425-9. PubMed ID: 3545148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The direct-acting mutagenicity of nitroimidazo[2,1-b]thiazoles in Salmonella typhimurium.
    Hrelia P; Paolini M; Biagi GL; Cantelli-Forti G
    Teratog Carcinog Mutagen; 1986; 6(6):511-9. PubMed ID: 2881366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitrichomonad action, mutagenicity, and reduction of metronidazole and other nitroimidazoles.
    Lindmark DG; Müller M
    Antimicrob Agents Chemother; 1976 Sep; 10(3):476-82. PubMed ID: 791102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the mutagenicity of nitroimidazoles.
    Voogd CE
    Mutat Res; 1981 May; 86(3):243-77. PubMed ID: 6457989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenicity of a series of 25 nitroimidazoles and two nitrothiazoles in Salmonella typhimurium.
    Cantelli-Forti G; Aicardi G; Guerra MC; Barbaro AM; Biagi GL
    Teratog Carcinog Mutagen; 1983; 3(1):51-63. PubMed ID: 6132457
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.